Introduction
Medication management in a hospital setting is an integral part of the functioning of every healthcare institution. It is a comprehensive set of processes that includes planning, procurement, distribution, record-keeping, dispensing, administration, monitoring, and evaluation of the effects of drugs administered to patients during hospitalization. Ensuring effective medication management is now a priority not only from the perspective of clinical effectiveness but also from the aspects of economic sustainability and patient safety.
In recent decades, we have witnessed rapid development in pharmacotherapy, which brings new challenges and demands for hospital facilities. The range of available medications is constantly expanding, and with it grows the complexity of their use – especially in patients with multiple chronic conditions, polypharmacy, and risk factors such as age, renal or hepatic insufficiency. Therefore, it is essential to ensure not only logistical coverage of drug consumption but also the implementation of systems that help prevent medication errors, interactions, and unnecessary waste.
The aim of this article is to examine in detail the structure and functioning of medication management in a hospital setting, identify the main challenges and risks, point out current shortcomings in the Slovak system, and outline promising directions for development. The article draws on domestic and international experience, professional studies, case analyses, and examples of good practice. It provides practical recommendations for hospital managers, healthcare personnel, and health policymakers to improve the effectiveness, safety, and quality of pharmacotherapy in a hospital setting.
1. Medication Management
Modern medication management has long been more than just "supplying departments with drugs." Today, it is a strategically managed system that encompasses a wide range of activities – from selecting medications based on Evidence-Based Medicine (EBM), through procurement, consumption monitoring, expiry control, to interventions by clinical pharmacists at the patient's bedside. A multidisciplinary approach is coming to the fore, involving collaboration among physicians, pharmacists, nurses, IT specialists, hospital managers, and health insurance companies.
In the Slovak hospital environment, medication management is primarily shaped by legislation, decrees, and methodological guidelines of the Ministry of Health of the Slovak Republic, rules of the State Institute for Drug Control (ŠÚKL), as well as recommendations from the Slovak Chamber of Pharmacists and the European Association of Hospital Pharmacists (EAHP). In practice, these standards are translated into specific organizational and procedural structures – such as drug committees, hospital formularies, prescribing rules, and systems for tracking dispensing and consumption.
In Slovakia, there are differences between individual hospitals in the level of digitalization of medication management, the availability of hospital pharmacists, and technical equipment. While some university hospitals have already introduced electronic prescribing, automated dispensing systems, or barcode technologies, other healthcare facilities still operate in a manual mode with a high risk of medication errors.
An important aspect of medication management is also the financial pressure that hospitals face. Medication costs constitute a significant part of the total hospital budget, and therefore it is essential to find a balance between the availability of innovative therapies and budget sustainability. This requires advanced pharmacoeconomic evaluation, thorough consumption planning, and optimization of the drug portfolio.
Last but not least, medication management also touches upon issues of ethics, transparency, and safety. Any error in the process of prescribing, dispensing, or administering a drug can lead to serious adverse events, including harm to health or even the death of a patient. For this reason, developed healthcare systems place great emphasis on creating a safety culture, supporting incident reporting (known as CIRS – Critical Incident Reporting Systems), and continuous education for all involved professionals.
2. Legislative and Organizational Framework in the Slovak Republic
Medication management in a hospital setting in the Slovak Republic is strictly regulated by legislation that sets rules not only for the purchase, dispensing, and record-keeping of drugs but also for the organization of hospital pharmacies, the status of pharmacists, and the reimbursement of medicines. The legal framework is formed by several laws and decrees, with the foundation being Act No. 362/2011 Coll. on Medicines and Medical Devices, also known as the "Medicines Act." This act regulates the conditions for placing medicines on the market, the rules for their sale and dispensing, as well as the requirements for facilities that handle medicines – including hospitals and hospital pharmacies.
2.1 Conditions for the Operation of a Hospital Pharmacy
For a hospital pharmacy to operate, it must obtain permission from the State Institute for Drug Control (ŠÚKL). Permission is granted only if the applicant meets strict criteria regarding: • Personnel provisions: The pharmacy must have qualified professional staff, especially pharmacists with specialization in the relevant fields. The professional representative can only be a pharmacist who has passed the certification examination. • Material-technical equipment: The equipment must include spatially separated rooms for the preparation of individual medications (including sterile preparations), cytostatics, and infusion solutions. • Operational standards: Operations must comply with Good Pharmacy Practice (GPP), which means ensuring hygienic standards, documentation, and quality control.
2.2 Specialization of the Hospital Pharmacist
The role of the hospital pharmacist in Slovakia has long been perceived as logistical and technical, but with increasing demands for treatment safety, his position is shifting towards clinical support. Pharmaceutical specialization in the Slovak Republic is regulated by a decree of the Ministry of Health, and hospital pharmacists typically undergo specialization in the field of pharmacy or clinical pharmacy.
Since 2018, a new model of postgraduate education has been introduced, allowing hospital pharmacists to complete a 2-year clinical program focused on acquiring competencies in individual counseling, treatment risk assessment, dosage optimization, and interactions. This program is gradually becoming a standard, especially for chief hospital pharmacists, for whom mandatory implementation of this qualification is planned.
Within the European Association of Hospital Pharmacists (EAHP), Slovakia actively participates in the harmonization of education, with the goal of creating a common competency framework for hospital pharmacists throughout the EU.
2.3 Financing of Medicines in Hospitals
An important aspect of medication management is the financing of medicines administered to hospitalized patients. According to Slovak regulations, these medicines are fully reimbursed from public health insurance, which means that patients do not pay any co-payments for medications during hospitalization. The exception is cases involving an individual request for an unregistered medicine or treatment outside the approved indication without reimbursement.
However, financing is not "automatic." Every drug that a hospital wants to include in its hospital formulary must be included in the so-called reimbursement list under Act No. 363/2011 Coll. on the Scope and Conditions of Reimbursement of Medicines. This act establishes the principles of categorization, price referencing, as well as rules for the use of generic and biosimilar drugs.
Therefore, hospitals must consistently optimize drug selection in terms of: • Price and reimbursement: Drugs with a lower price and comparable therapeutic effectiveness are preferred. • Availability: The selection of suppliers is conditional on the ability to ensure continuous supply. • Economic value: Drugs with a favorable cost-effectiveness ratio are prioritized. • Agreements with insurers: Some drugs are conditional on the approval of a review physician or a contract for exceptional reimbursement.
In recent years, centralized drug purchasing, overseen by the Ministry of Health or the state company National Centre of Health Informatics (NCZI), is increasingly being applied. This system aims to ensure transparency, lower prices, and control over the consumption of especially high-cost drugs. At the same time, it creates pressure for benchmarking – comparing drug prices, expenditure, and consumption between individual hospitals.
2.4 Drug Committees and Formularies
Every hospital is legally obliged to create a drug committee, which has decision-making authority over the inclusion of drugs in the internal hospital formulary. The committee has interdisciplinary representation – it usually consists of the chief pharmacist, chief physician, department representatives, and the financial director.
Decision-making is based on: • Evidence-Based Medicine (EBM), • Pharmacoeconomic analyses, • Clinical practice and staff experience.
The formulary then serves as a reference list of drugs that are routinely available in the hospital and are the primary focus of consumption. Exceptions are only possible upon approval of an individual prescription.
3. Structure of Medication Management in Hospitals
Medication management in a hospital setting is a multidisciplinary process that requires coordinated cooperation between several organizational components of the hospital. From ensuring the availability of drugs to their correct administration and evaluation of effectiveness, this process involves professionals from the fields of pharmacy, clinical medicine, logistics, informatics, and healthcare management. The basic pillars of this structure are the drug committee, the hospital pharmacy, clinical pharmacy departments and special drug preparation units, the logistics and storage system, as well as the information infrastructure that ensures the transparency and effectiveness of the entire system.
3.1 Drug Committee – Strategic Decision-Making
The drug committee is a key decision-making body within the hospital's medication management. Its task is to create and update the hospital drug formulary, evaluate new therapeutic options, approve individual exemption requests, and establish internal rules for the use of selected medications.
The committee's composition is interdisciplinary: it usually consists of the hospital's chief physician, chief pharmacist, representatives of individual specialist departments, the financial director, or another member of the hospital's management. In many cases, representatives of clinical pharmacy or specialized physicians who present professional opinions on proposed changes in drug policy are also part of it.
Decision-making principles are based on Evidence-Based Medicine (EBM), with clinical study results, specialist society recommendations, and pharmacoeconomic analyses carrying decisive weight. When evaluating new drugs, the committee also considers the safety profile, clinical benefit, cost-effectiveness, and availability of alternatives.
The outcome of the committee's work is the hospital formulary – an internal document containing a list of drugs approved for use in the hospital. This list is regularly updated and serves as a reference document for prescribing physicians and the hospital pharmacy.
3.2 Hospital Pharmacy – The Operational Center
The hospital pharmacy is the basic logistical and professional center responsible for the procurement, storage, dispensing, record-keeping, and preparation of drugs. Its scope of responsibility includes managing drug stocks, checking expiry dates, recording batches, as well as preparing individually compounded medications – from common solutions to highly specialized sterile preparations and cytostatics.
The professional management of the pharmacy is under the responsibility of the hospital pharmacist, who, in addition to leading the team, is also responsible for the quality of services provided, compliance with Good Pharmacy Practice, and ensuring conformity with legislative requirements. The pharmacist oversees the proper execution of orders, collaborates with distributors and suppliers, and communicates with clinical departments in case of drug shortages or interruptions.
The pharmacy also includes a drug compounding area, where individual medications are prepared, especially infusion solutions, parenteral nutrition, ophthalmic preparations, inhalation solutions, and other specific drugs tailored to the patient's needs. In the case of cytostatic preparation, a specially equipped isolator or laminar box and strict adherence to safety protocols are required.
3.3 Clinical Pharmacy – Professional Oversight of Therapy
In recent years, clinical pharmacy, which represents a professional segment of pharmaceutical practice directly at the patient's bedside, has been gaining importance. The clinical pharmacist is not just a passive provider of drugs but actively participates in optimizing pharmacotherapy, identifying drug interactions, monitoring high-risk patients (e.g., elderly patients, polymorbid patients, patients in intensive care units), and reducing the occurrence of adverse effects.
Among the most important tasks of the clinical pharmacist are: • Analysis of prescriptions in terms of suitability of treatment, dosage, and duplications. • Collaboration with physicians in setting individualized treatment regimens. • Working with high-risk patient groups – for example, geriatric patients with polypharmacy or patients with renal and hepatic impairment. • Conducting pharmaceutical consultations and educating healthcare personnel on safe drug administration. • Analysis of drug consumption and identification of potential savings and inefficiencies in the system.
The presence of clinical pharmacists on hospital wards significantly contributes to reducing the occurrence of medication errors, improving treatment outcomes, and more efficient use of available resources.
3.4 Storage and Logistics Department
Effective logistics is a fundamental prerequisite for functional medication management. Hospitals often establish a specialized storage and dispensing department, which ensures: • Receipt of goods from suppliers. • Recording of batches and expiry dates in compliance with ŠÚKL requirements. • Storage of drugs under conditions that ensure their stability (cold storage, secure areas for narcotic substances). • Daily dispensing of drugs to departments as required.
In modern hospitals, logistics are often supported by information systems that enable automated ordering, electronic inventory tracking, alerts for drug shortages, and control over the distribution of expensive drugs. Some hospitals already use automated dispensing systems (so-called drug cabinets), which serve as smart pharmacies on the wards and allow for precise tracking and monitoring of dispensing.
3.5 Electronic and Digitalized Processes
An important part of the modern medication management structure is digitalization and the use of electronic systems. These increase efficiency, reduce errors, and allow for better control over the movement of drugs within the hospital. The most significant areas of digitalization include: • Electronic prescribing systems (eP) – allow physicians to enter prescriptions directly into the system, minimizing the risk of interpretation errors. • Barcode systems – ensure the correct drug is given to the right patient at the right time. • Inventory management software – used to track stocks, evaluate consumption, and automate ordering. • Electronic medication administration records (eMAR) – a digitalized documentation system that replaces paper records.
4. Process Components of Medication Management
Medication management in a hospital is not a one-time activity but a dynamic process that occurs in several interconnected phases. Each of these phases – from drug selection, procurement, storage, distribution, prescribing, administration, to monitoring effectiveness and retrospective evaluation – forms process components that together ensure a functional and safe system for working with medicines. In this chapter, we will examine in detail the individual components, their functions, risks, and optimization possibilities.
4.1 Drug Selection and Formulation of the Hospital Formulary
The entire medication cycle begins with the process of selecting drugs to be used in a specific hospital facility. This selection is handled by the drug committee, which makes decisions based on: • Evidence-Based Medicine (EBM) • Therapeutic needs within the hospital's specialization • Pharmacoeconomic effectiveness (e.g., cost-effectiveness, QALY) • Health insurance reimbursement policies • The safety profile of the medicines The result is the hospital formulary, which represents the official list of drugs available in a given healthcare facility. The formulary is regularly updated – sometimes quarterly, other times annually – based on changes in clinical recommendations, supply shortages, or the entry of new drugs onto the market. It is important to note that the formulary is not merely an administrative document but a strategic tool for cost management and quality of care.
4.2 Procurement and Purchase of Medicines
After drug selection follows their procurement, which is subject to public procurement under Act No. 343/2015 Coll. on Public Procurement. This process involves selecting suppliers, negotiating prices, guaranteeing deliveries, and ensuring contractual conditions. In many cases, centralized purchasing (e.g., through NCZI) is preferred, which ensures more favorable contractual terms.
Key challenges in this process: • Frequent shortages of certain drugs • Suppliers unable to guarantee delivery times • Prices exceeding insurance reference limits • Insufficient flexibility for urgent needs Modern procurement platforms allow electronic ordering, purchase history tracking, price comparison, and statistical consumption evaluation – which significantly streamlines inventory management.
4.3 Receipt, Storage, and Record-Keeping
After the delivery of medicines follows their receipt and registration into the system. At this stage, it is necessary to: • Check batches, expiry dates, and packaging integrity • Record the drugs in the internal system (LIS or other software) • Store the drugs according to recommended storage conditions (cold chains, secured areas for narcotic substances)
The storage and logistics department ensures the physical management of inventory, regular inventory counts, and monitoring of minimum stock levels (so-called safety stock). Many hospitals implement automated storage systems that reduce the number of errors and allow for rapid searching and distribution.
Proper storage also involves the segregation of medicines: • Cytostatics and high-risk preparations in separate warehouses • Refrigerated medicines at 2–8 °C • Narcotic and psychotropic substances in locked safes
4.4 Prescription of Medicines
Prescribing represents one of the most critical points in the entire medication management process. It is the physician's decision on a specific treatment regimen for the patient. Prescriptions can be: • Manual (traditionally handwritten) • Electronic (e-Prescribing)
When prescribing, it is necessary to consider: • The diagnosis and clinical condition of the patient • Possible interactions with other medications • Dosage in accordance with renal/hepatic function • Allergies, age, and BMI of the patient • Compliance with the hospital formulary
Clinical pharmacists often collaborate with physicians in reviewing prescriptions – pointing out duplications, contraindications, or inappropriate combinations. If necessary, they recommend alternatives or adjust dosages.
4.5 Dispensing of Medicines and Their Distribution to Departments
Dispensing is carried out by the hospital pharmacy based on: • Regular quotas (e.g., daily for each department) • Individual requests for urgent treatment • Dispensing for specialized regimens (chemotherapy, biological therapy)
Distribution occurs either: • Centrally – drugs are dispensed for the entire department • Decentralized – dispensing "by name" to the patient (e.g., intensive care units) In modern hospitals, automated dispensing units – so-called "med cabinets" – are used, which track who dispensed the drug, when, for whom, and in what quantity. These systems significantly contribute to traceability and dispensing safety.
4.6 Administration of Medicines to the Patient
The administration phase is the responsibility of the nursing staff – most often general or specialized nurses. For the process to be safe, the following principles must be observed: • Right patient • Right drug • Right dose • Right time • Right route
These principles are known as the "5Rs" principle (Right patient, Right drug, Right dose, Right time, Right route).
Currently, electronic medication administration systems (eMAR) are increasingly being used, which: • Remind about administration • Record the time and person who administered the drug • Allow scanning of the drug's barcode and the patient's barcode
These systems significantly reduce errors and allow for precise retrospective review.
4.7 Monitoring, Evaluation, and Feedback
A key component of modern medication management is monitoring the effectiveness and safety of pharmacotherapy. This part includes: • Collecting data on administered drugs • Evaluating the patient's response (clinical effect, side effects) • Recording adverse events (ADR reporting) • Pharmacoeconomic retrospective analysis (consumption, effectiveness)
The task of clinical pharmacists and quality managers is to collect this data, analyze it, and propose optimization measures – for example, adjusting dosage protocols, training personnel, or reviewing the hospital formulary.
It is also important to systematically report medication errors and incidents. Systems like CIRS (Critical Incident Reporting System) allow for anonymous reporting and analysis of near-misses and adverse events to prevent their recurrence.
5. The Role of Healthcare Personnel and Interprofessional Collaboration
Medication management in a hospital setting is a multidisciplinary process that requires close collaboration among various professions in the healthcare team. Each team member has their specific role, competencies, and responsibilities. Ensuring the safe, effective, and economically sound use of medicines is only possible if there is open communication, trust, and coordinated action among the different professions. Interprofessional collaboration thus becomes one of the most fundamental elements of modern hospital practice and directly affects the quality of healthcare.
5.1 Key Professions Involved in Medication Management
Physicians – Clinical decision-making - The physician is the main bearer of clinical responsibility for the patient and plays a decisive role in prescribing medications. Their role includes: • Diagnosis and determination of the therapeutic goal • Selection of the most suitable drug from the hospital formulary • Dosage of the drug considering individual patient parameters (age, weight, renal and hepatic function) • Ongoing monitoring of the drug's effect and adjustment of therapy as needed
The physician must also consider pharmacoeconomic and reimbursement aspects of prescribed drugs; increasingly, knowledge of the hospital's drug policy and collaboration with other team members are expected.
Pharmacists – Exercise professional oversight over treatment safety. The hospital pharmacist performs multiple functions that go beyond the traditional dispensing of medicines. Their role is evolving towards clinical support, which includes: • Providing professional consultations to physicians on the suitability of treatment • Reviewing prescriptions for interactions, duplications, contraindications • Individual dosing of medicines for specific patients (e.g., renally insufficient) • Educating healthcare personnel about new drugs and safety recommendations • Preparing individual drug forms (cytostatics, infusion solutions, parenteral nutrition)
At the same time, they participate in analytical activities – monitoring drug consumption, identifying adverse effects, and proposing changes to protocols.
Nurses – Ensure safe administration and patient monitoring. Nurses are the final link in the medication chain – they administer the drug to the patient. Their role, however, is far from just executive. It includes: • Verifying the correctness of administration (5Rs rule: right patient, drug, dose, time, route) • Identifying and reporting adverse reactions • Maintaining electronic documentation (eMAR) • Collaborating in the introduction of new medication regimens • Communicating with the patient about treatment (explaining effects, method of administration)
Nurses are often the first to identify problems with adherence, treatment reactions, or ambiguities in the medication regimen – and are therefore key partners for pharmacists and physicians.
Other professions – Provide quality support. Among other professions that significantly contribute to safe medication management are: • Laboratory diagnosticians – provide data necessary for dosing (e.g., creatinine, plasma drug levels) • IT specialists – ensure electronic prescribing systems, barcode systems, data security • Quality and risk managers – analyze error reports and implement preventive measures • Healthcare assistants – support nursing personnel in basic medication care (within their competencies)
5.2 The Importance of Interprofessional Communication
One of the most common causes of medication errors is insufficient or ambiguous communication between healthcare professions. Therefore, it is important to create systems that support collaboration, such as: • Joint ward rounds – involving physicians, nurses, and clinical pharmacists • Multidisciplinary meetings – especially for complex patient cases (e.g., intensive care, oncology) • Shared electronic records – allowing all team members access to information on administered drugs, results, and notes • Educational activities – trainings, workshops, case studies involving all professions
Interprofessional communication is the foundation of safety – it reduces the risk of duplication, dosage errors, and allows for a faster response to adverse effects.
5.3 Shared Responsibility and Safety Culture
A key aspect of collaboration is creating a safety culture where every team member feels responsible for the patient and is encouraged to take an active approach. Basic principles include: • Low tolerance for errors, but a high willingness to report them and learn from them • Openness to feedback – between professions, without hierarchical pressure • Sharing information – for example, about new risks, adverse events on other departments, or changes in drug policy • Reflective practice – retrospective case evaluation, analysis of critical incidents
Among the institutions supporting this approach is the World Health Organization (WHO), which recommends the introduction of multidisciplinary drug teams, especially when working with vulnerable patient groups.
5.4 Barriers to Collaboration and Ways to Overcome Them
Despite the clear benefits of interprofessional collaboration, several barriers are still encountered in practice: • Hierarchical barriers – some professions may feel inferior or marginalized • Lack of time – high workload limits the possibility of joint meetings or consultations • Differences in professional language – differing understanding of terminology between physicians and pharmacists • Fear of responsibility – fear of pointing out colleagues' errors
The solution to these problems lies in systematically building an interprofessional culture already during university studies, as well as introducing standardized collaboration protocols where each team member has a clearly defined role and the right to express their opinion.
5.5 Examples of Good Practice
From the hospital setting, we can cite examples where interprofessional collaboration yields measurable results. Joint clinical-pharmaceutical ward rounds in intensive care units, where the pharmacist points out inappropriate combinations and adjusts dosages based on current laboratory parameters.
6. Technological Components and Digitalization in Medication Management
The digitalization of healthcare is a key tool for improving patient safety, system efficiency, and process transparency. In the field of medication management, technologies are applied across the entire spectrum of activities – from electronic prescribing, through automated dispensing, storage, monitoring, to feedback and reporting. In this chapter, we will present the main technological components, their functions, benefits, and challenges in the context of the Slovak hospital environment.
6.1 Electronic Prescribing (e-Prescribing)
Electronic prescribing (e-Prescribing) is among the most significant changes in the field of medication prescribing. In the Slovak Republic, it has been introduced mainly in the outpatient sector, but its application in hospital care is still under development. It is a process in which a physician enters a prescription electronically into a system that is subsequently accessible to pharmacists and nursing staff.
Main benefits of e-Prescribing: • Elimination of errors caused by illegible handwriting • Reduced risk of duplications and contraindications • Integration with the patient's electronic health record • Possibility of central control of prescribing and drug consumption • Ability to set system restrictions based on the hospital formulary
In a hospital setting, e-Prescribing also allows direct interaction with the clinical pharmacist, who can analyze dosing accuracy in real-time, alert to risky interactions, and suggest therapy adjustments.
6.2 Information Systems for Managing Drug Logistics (LIS, WMS)
Logistical information systems (e.g., LIS – Drug Information System, or WMS – Warehouse Management System) play an important role in the storage, dispensing, and tracking of drug movement within the hospital.
Functionalities of these systems: • Recording of batches, expiry dates, and warehouse stocks • Automatic generation of orders when stock falls below a defined level • Integration with the hospital's invoicing and accounting system • Reporting of drug consumption by department or therapeutic group • Management of drug dispensing – either from a central warehouse or via automated dispensing units
The use of these systems allows the hospital to reduce waste, optimize purchasing decisions, and prevent shortages of critical drugs. Thanks to detailed record-keeping, every dispensed drug can be traced back – which is crucial in case of complaints, treatment failure, or suspicion of counterfeiting.
6.3 Automated Dispensing Systems ("drug cabinets")
Many modern hospitals are implementing automated dispensing units, also known as "med cabinets" or "drug cabinets." These are lockable, electronically controlled cabinets or carousels located directly on the wards and dispense drugs based on authorized access.
Main benefits: • Significant reduction in dispensing errors (the system alerts to incorrect drug selection) • Documentation of every dispensing event (who, when, for whom, what, and how much) • Ability to set restrictions for high-risk drugs (e.g., psychotropic substances) • Time-saving – nurses do not have to go to the central pharmacy for medications • Reduction of drug losses and misuse
These systems are particularly important in intensive care, anesthesiology, oncology, and geriatrics, where high-risk or expensive drugs are frequently administered.
6.4 Electronic Medication Administration Records (eMAR)
eMAR (Electronic Medication Administration Record) is an electronic form of documentation of drug administration. It allows nurses and physicians to record: • Exact time of drug administration • Method and route of administration • Patient's response • Deviations (e.g., delay, omission, substitution)
One of the greatest benefits of eMAR is its connection to the prescribing system and inventory. This achieves complete continuity – from prescription, through dispensing, to drug administration to the patient. Moreover, barcodes can be integrated, which the nurse scans from both the drug and the patient's wristband – significantly reducing the risk of incorrect administration.
The eMAR system also allows for: • Reminders of scheduled administrations • Automatic generation of reports for pharmacists • Documentation of any side effects or reactions
6.5 Monitoring and Analytics (BI tools)
A major advantage of a digitalized medication system is the possibility of data analysis. Business Intelligence (BI) tools allow: • Evaluation of drug consumption by department, diagnosis, or DRG group • Identification of over-prescribing or waste • Monitoring of high-risk drug administration • Analysis of adverse effect occurrence and their relation to treatment
These data are crucial for: • Hospital managers (strategic planning and procurement) • Clinical pharmacists (therapy optimization) • Insurers and regulatory authorities (audit, reimbursement, standardization)
Digitalized data can also be used for benchmarking – comparing hospitals in terms of drug effectiveness and safety.
6.6 Barcode Systems and RFID Technology
To enhance the safety of the medication chain, barcodes and RFID chips are increasingly being used. Every drug, patient, and nursing staff member can be uniquely identified.
Practical use of barcodes: • When receiving drugs (verifying batch, expiry date) • When dispensing to the ward (checking the correct drug) • When administering to the patient (identifying drug + patient)
RFID technology, in turn, allows: • Rapid location of drugs in the warehouse • Alerts for expiry or dispensing errors • Real-time connection to recording systems
These technologies fundamentally reduce the occurrence of medication errors, increase traceability, and ensure better control over sensitive drug groups (e.g., biologics, narcotics).
6.7 System Integration and Interoperability
For the full utilization of all digital tools, it is essential that the systems are interconnected. Ideally, there should be an integrated hospital information system (HIS) that connects: • Electronic health records • Prescribing module • Drug dispensing and logistics • eMAR • Laboratory and diagnostic results
System interoperability is a prerequisite for: • The clinical pharmacist to be able to respond to laboratory values in real-time • The physician to see when and how the drug was administered • The hospital management to obtain accurate, comprehensive data for decision-making
7. Patient Safety, Risks, and Reporting Culture in Medication Management
In a hospital setting, patient safety is the highest priority. Despite technical progress, digitalization, and improved organization, serious medication errors that can endanger the health and even the life of patients still occur. Medication management is a complex chain of activities where even a small error in one link can have fatal consequences. Therefore, patient safety cannot be perceived as a one-time goal but as a continuous process requiring the attention of all stakeholders – physicians, nurses, pharmacists, management, and patients themselves.
7.1 Medication Errors as a Threat to the Patient
According to the World Health Organization (WHO), medication errors are one of the most common causes of patient harm in healthcare. These errors can occur at any point in the medication chain: • When prescribing a drug – incorrect selection of drug, dose, frequency, or form • When dispensing – dispensing the wrong drug or incorrect quantity • When administering – incorrect patient identification, wrong route of administration, wrong time • When monitoring the effect – delayed detection of adverse effects or interactions
Among the most common factors leading to errors are: • Unclear or incomplete documentation • Poor communication among healthcare team members • Insufficient patient education • Work overload and staff stress • Lack of knowledge about medications (especially for new drugs)
Serious consequences of medication errors can include hospitalization complications, worsening of the underlying condition, prolonged recovery, permanent sequelae, or even death. In many cases, however, medication errors are preventable if a system of prevention, early recognition, and risk management is established.
7.2 Classification of Medication Errors
Medication errors can be classified according to the severity of their impact on the patient. In hospital practice, the classification by NCC MERP (National Coordinating Council for Medication Error Reporting and Prevention) is often used, which includes categories from A (error with no impact) to I (error that contributed to patient death). • Category A – error intercepted before reaching the patient • Category B-D – error reached the patient but did not cause harm • Category E-H – error caused temporary to permanent health impairment • Category I – error caused death
This classification serves not only for documentation but also for risk analysis and setting corrective measures. Thanks to feedback from incidents, the occurrence of similar errors can be reduced in the future.
7.3 Preventive Measures to Reduce Risk
Safe medication management must be built on systems that actively prevent errors. Key prevention strategies include: 1. Standardization of procedures The introduction of Standard Operating Procedures (SOPs) for prescribing, dispensing, and administering medications reduces variability in practice. These protocols contain recommended dosages, contraindications, and alternatives in case of shortages. 2. Digitalization and control mechanisms Electronic prescribing systems (e-Prescribing), eMAR, barcodes, RFID technology, and automatic alerts for interactions help minimize human errors. Clinical decision support systems (CDSS) additionally assist physicians in selecting optimal treatment. 3. Double-checking and auditing In high-risk cases (e.g., chemotherapy, pediatric doses), the so-called four-eye principle – double-checking before drug administration – is introduced. Pharmacists also conduct prescription reviews and participate in drug consumption audits. 4. Education and training Regular training of healthcare personnel on new drugs, risks, dosages, and protocols is an essential part of prevention. Simulation-based learning is also significant – practicing crisis situations, drug administration under time pressure, and proper documentation.
7.4 Safety Culture and Incident Reporting
The modern approach to patient safety is based on the principle of "learning from mistakes" – that is, learning from errors, not punishing for them. However, this requires an open and non-hierarchical culture where healthcare workers are not afraid to report errors: 1. CIRS – Incident Reporting System CIRS (Critical Incident Reporting System) is an anonymous or named system where employees can report: • Medication errors • Near misses • Adverse drug reactions • Logistical and communication failures
The task of CIRS is not to blame individuals but to analyze systemic failures and propose improvements. Each report should be evaluated, classified, and communicated back – ideally in the form of "learning points."
- Management and leadership support A safety culture cannot exist without the active participation of hospital management. Management should create an environment of trust, support employees in reporting errors, and ensure the implementation of corrective measures.
- Transparency and knowledge sharing It is important not only to report but also to share experiences between departments and hospitals. Case studies, anonymized incident analyses, and interdisciplinary meetings help build collective experience and prevention.
7.5 High-Risk Situations and Patient Groups
Certain situations and patient groups require a special approach due to a higher risk of errors: • Pediatric patients – weight-based dosing, risk of unit confusion • Geriatric patients – polymorbidity, risk of interactions and reduced metabolic capacity • Patients in intensive care – multiple intravenous drugs, need for precise timing and compatibility • Oncology patients – administration of cytostatics, need for individualized preparation and protective measures
For these situations, special protocols, checklists, and technological tools (e.g., gravimetric weighing of infusion solutions, barcode scanning) are often introduced.
8. Nurses in Medication Management
Nurses represent one of the most important links in the process of medication management in a hospital setting. Their daily practice, knowledge, experience, and observations provide a unique and irreplaceable perspective on the functioning of the entire drug safety system. Nurses are not only the executors of drug administration itself but are often also informal controllers of quality and safety who can detect possible shortcomings or errors in a timely manner. Based on a summary of their experiences, key areas can be identified that affect patient safety and simultaneously offer opportunities to improve the entire medication management process.
8.1 The Significance of Nurses' Experiences in Medication Management
Nurses' experiences are a valuable source of information about real-world conditions and problems that occur in practice during the preparation, dispensing, and administration of medicines. Nurses often work in a demanding and stressful environment where high accuracy and speed are expected. In all this, they are frequently exposed to the pressure of insufficient resources, inadequate workspaces, unclear processes, and frequent interruptions. These factors significantly influence the risk of medication errors occurring.
An important finding is that nurses perceive several systemic weaknesses that negatively affect the safety of medication management. These include inconsistency and fragmentation of medication preparation areas, insufficient frequency of stock checks, weak education on managing adverse reactions, or the absence of a culture of open incident reporting. Significant factors are also workload and stress, which can lead to human errors.
8.2 Work Environment Problems and Their Impact on Safety
One of the key problems that nurses often emphasize in practice is the existence of multiple functional medication preparation areas in a department. These preparation rooms differ in equipment, layout, hygiene, and often ergonomics. In such an inconsistent environment, there is a higher risk of errors in drug preparation, such as confusion of drugs with similar packaging or mix-up of drug concentrations.
Inadequate ergonomic conditions, such as insufficient lighting, limited workspace, and missing aids, increase the risk when working under time pressure and the necessity of multitasking. These factors directly affect the reduction in concentration and thus the safety of drug administration. Last but not least, they contribute to the mental exhaustion of healthcare personnel.
8.3 The Importance of Regular Checks and Inventory Management
Another significant problem to which nurses draw attention is the low frequency of medication inventory checks. In many facilities, medication inventory is performed only once a month, which represents a significant safety risk. Insufficient checking can lead to the use of expired drugs, improper storage, as well as inefficient inventory management, which endangers the availability of key medications in critical situations.
Nurses emphasize the need for daily or at least regular checks of medications directly on the ward, including monitoring expiry dates and proper storage conditions. Modern digital inventory management systems can significantly streamline these processes and reduce the risk of human error.
8.4 Insufficient Education on Adverse Reactions
One of the strongest negative trends is the lack of regular training and education that would help nurses better identify and manage adverse drug reactions. Statistics show that only about 6% of workplaces provide such regular education, which is alarming given the importance of timely response to allergic or other adverse effects.
The absence of systematic preparation leads to late or incorrect reactions, which can have serious and even life-threatening consequences. Education should include not only theoretical knowledge but also practical simulations of crisis situations and clear protocols for action in case of allergic reactions or other urgent conditions.
8.5 The Impact of Workload and Multitasking
The workload of nurses is another significant factor affecting the safety of medication management. Nurses often perform multiple tasks simultaneously, and their work is frequently interrupted, which negatively affects their ability to maintain attention during critical procedures such as medication preparation and administration. Multitasking and frequent interruptions are a common cause of errors, which can result in incorrect drug administration, dosage, or patient mix-up. Creating distraction-free zones for medication preparation, clear communication rules, and respecting work procedures are essential steps to reduce this risk.
Summary
Effective and safe medication management represents an integral part of modern healthcare and is one of the key factors of care quality in a hospital setting. Slovak hospitals have made significant steps towards its improvement in recent years, but much work still lies ahead.
The integration of technologies, expanding the role of clinical pharmacists, educating healthcare personnel, and building a safety culture are the main directions that need to be consistently developed. In this process, cooperation among all involved professions and support from management and the state are essential.
Authors: PhDr. Bc. Mgr. Marcel Tóth, PhD. MPH, Mgr. Adriana Vasiková Bc. Iveta Kalúsová Natália Wengová, Dipl. s Ružena Píšová, Dis.
Literature:
- Urbančičák, F., Wylegała, K., Religioni, U., Czech, M., & Dědeček, P. (2023). Recommendations for wider adoption of clinical pharmacy in Central and Eastern Europe in order to optimise pharmacotherapy and improve patient outcomes. Frontiers in Pharmacology, 14, 1244151. https://doi.org/10.3389/fphar.2023.1244151
- Wylegała, K., Religioni, U., & Czech, M. (2023). The impact of hospital pharmacy operation on the quality of patient care. International Journal of Environmental Research and Public Health, 20(5), 4137. https://doi.org/10.3390/ijerph20054137
- Mouazer, A., Léguillon, R., & Yacoubi, M. E. H. (2023). ABiMed: An intelligent and visual clinical decision support system for medication reviews and polypharmacy management. arXiv preprint. https://arxiv.org/abs/2312.11526
- Chalasani, S. H., Syed, J., Khan, R., & Kamath, A. (2023). Artificial intelligence in pharmacy practice: A literature review. Exploratory Research in Clinical and Social Pharmacy, 10, 100332. https://doi.org/10.1016/j.rcsop.2023.100332
- Hajduchová, H., Červený, M., Brabcová, I., & Chloubová, I. (2024). Medication administration errors in the selected Czech hospitals: An observational study. Nursing in the 21st Century, 23(1), Article 0009. https://doi.org/10.2478/pielxxiw-2024-0009
- Maříková, M., Očovská, Z., Vlček, J., & Malý, J. (2023). Drug-related hospitalisations in the Czech Republic: A review of causes and interventions. International Journal of Clinical Pharmacy, 45(2), 123–131. https://doi.org/10.1007/s11096-021-01237-y
- Brabcová, I., Hajduchová, H., Tóthová, V., Chloubová, I., Červený, M., Prokešová, R., Malý, J., Vlček, J., & Doseděl, M. (2023). Reasons for medication administration errors, barriers to reporting them and the number of reported medication administration errors from the perspective of nurses: A cross-sectional survey. Nurse Education in Practice, 70, 103642. https://doi.org/10.1016/j.nepr.2023.103642
- Bízková, H. (2024). New edition of the Czech Pharmacopoeia 2023 and what preceded it. Česká a slovenská farmacie, 73(1), 29–32. https://www.prolekare.cz/en/journals/czech-and-slovak-pharmacy/2024-1-29/new-edition-of-the-czech-pharmacopoeia-2023-and-what-preceded-it-139749
- Porubcová, S., Lajtmanová, K., Szmicseková, K., & Mišíková, E. (2025). PHAROS trial: Optimization of pharmacotherapy in vascular surgery patients in Slovakia. JMIR Research Protocols. https://pubmed.ncbi.nlm.nih.gov/40106812/
- Štempeľová, I., Takáč, O., Hirjaková, D., & Fedorová, M. (2023). Electronic health care in Slovakia from the perspective of pharmacists. In INTED2023 Proceedings. IATED Academy. https://doi.org/10.21125/inted.2023.1511
- NURIPH Risk Matrix Study. (2023). Patient safety in the process of pharmacotherapy carried out by nurses—A Polish–Slovak prospective observational study. Drug, Healthcare and Patient Safety, 15, 45–56. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8508261/
- Prášilová, S., Oleárová, A., Stašová, O., Kalina, M., & Klimas, J. (2023). Potentially inappropriate medications in hospitalized elderly patients assessed by using different tools—a monocentre retrospective analysis. EPMA Journal. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226434/